Nocathiacins, new thiazolyl peptide antibiotics from Nocardia sp. I. Taxonomy, fermentation and biological activities

Journal of Antibiotics

Volumn 56, Issue 3, 2003, Pages 226-231

  Li, Wenying ^a   Leet, John E ^a   Ax, Helen A ^a   Gustavson, Donald R ^a   Brown, Daniel M ^a   Turner, Laura ^a   Brown, Kimberly ^a   Clark, Junius ^a   Yang, Hyekyung ^a   Fung Tomc, Joan ^a   Lam, Kin S ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOCATHIACIN I; NOCATHIACIN II; NOCATHIACIN III; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; DRUG STRUCTURE; ENTEROCOCCUS FAECIUM; FEMALE; FERMENTATION; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MULTIDRUG RESISTANCE; NOCARDIA; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TAXONOMY;

ENTEROCOCCUS FAECIUM; NOCARDIA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0037361644     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.56.226     Document Type: Article

References (23)

1. DOERN, G. V.; M. A. PFALLER, K. KUGLER, J. FREEMAN & R. N. JONES: Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin. Infect. Dis. 27: 764-770, 1998
2. SPENCER, R. C.; A. BAUERNFEIND, J. GARCIA-RODRIGUEZ, V. JARLIER, M. PFALLER, J. TURNIDGE & A. ROSS: Surveillance of the current resistance of nosocomial pathogens to antibacterials. Clin. Microbiol. Infect. 3 (Suppl. 1): S21-S35, 1997
3. COHEN, M. L.: Antimicrobial resistance: prognosis for public health. Trends Microbiol. 2: 422-425, 1994
4. JONES, R. N.: The emergent needs for basic research, education, and surveillance of antibacterial resistance. Diagn. Microbiol. Infect. Dis. 25: 1-9, 1996
5. BROWN, K. S.: Pharmaceutical and biotech firms taking on drug-resistant microbes. The Scientist: 10: 8-9, 1996
6. STEINBERG, D. A.; V. S. BERNAN, D. A. MONTENEGRO, D. R. ABBANAT, C. J. PEARCE, J. D. KORSHALLA, N. V. JACOBUS, P. J. PETERSEN, M. J. MROCZENSKI-WILDEY, W. M. MAIESE & M. GREENSTEIN: Glycothiohexides, novel antibiotics produced by "Sebekia" sp., LL-14E605. I. Taxonomy, fermentation, and biological evaluation. J. Antibiotics 47: 887-893, 1994
7. NORTHCOTE, P. T.; D. WILLIAMS, J. K. MANNING, D. B. BORDERS, W. M. MAIESE & M. D. LEE: Glycothiohexide α, a novel antibiotic produced by "Sebekia" sp., LL-14E605. II. Isolation and physica-chemical characterization. J. Antibiotics 47: 894-900, 1994
8. NORTHCOTE, P. T.; M. SIEGEL, D. B. BORDERS & M. D. LEE: Glycothiohexide α, a novel antibiotic produced by "Sebekia" sp., LL-14E605. III. Structural elucidation. J. Antibiotics 47: 901-908, 1994
9. PORSE, B. T.; L. LEVIEV, A. S. MANKIN & R. A. GARRETT: The antibiotic thiostrepton inhibits a functional transition within protein L11 at the ribosomal GTPase centre. J. Mol. Biol. 276: 391-404, 1998
10. BENAZET, F.; M. CARTIER, J. FLORENT, C. GODARD, G. JUNG, J. LUNEL, D. MANCY, C. PASCAL, J. RENAUT, P. TARRIDEC, J. THEILLEUX, R. TISSIER, M. DUBOST & L. NINET: Nosiheptide, a sulfur-containing peptide antibiotic isolated from Streptomyces actuosus 40037. Experientia 36: 414-416, 1980
11. 13C nuclear magnetic resonance study. J. Chem. Soc. Chem. Comm. 1977: 706-708, 1977
12. KETTERNING, J.; L. COLOMBO, P. FERRARI, P. TAVECCHIA, M. NEBULONI, K. V'EKEY, G. G. GALLO & E. SELVA: Antibiotic GE2270 A: A novel inhibitor of bacterial protein synthesis. II. Structure elucidation. J. Antibiotics 44: 702-715, 1991
13. AOKI, M.; T. OHTSUKA, M. YAMADA, Y. OHBA, H. YASUNO, T. SANO, J. WATANABE, K. YOKOSE & H. SATO: Cyclothiazomycin, a novel polythiazole-containing peptide with rennin inhibitory activity. Taxonomy, fermentation, isolation and physico-chemical characterization. J. Antibiotics 44: 582-588, 1991
14. 13C-labeled amino acids. J. Am. Chem. Soc. 117: 7606-7610, 1995
15. SASAKI, T.; T. OTANI, H. MATSUMOTO, N. UNEMI, M. HAMADA, T. TAKEUCHI & M. HORI: MJ347-81F4 A & B, novel antibiotics from Amycolatopsis sp.: Taxonomic characteristics, fermentation, and antimicrobial activity. J. Antibiotics 51: 715-721, 1998
16. LEET, J. E.; W. LI, H. A. AX, J. A. MATSON, S. HUANG, R. HUANG, J. L. CANTONE, D. DREXLER, R. A. DALTERIO & K. S. LAM: Nocathiacins, new thiazolyl peptide antibiotics from Nocardia sp. II. Isolation, characterization, and structure determination. J Antibiotics 53: 232-242, 2003
17. CONSTANTINE, K. L.; L. MUELLER, S. HUANG, S. ABID, K. S. LAM, W. LI & J. E. LEET: Conformation and absolute configuration of nocathiacin I determined by NMR spectroscopy and chiral capillary electrophoresis. J. Am. Chem. Soc. 124: 7284-7285, 2002
18. SHIRLING, E. B. & D. GOTTLIEB: Methods for characterization of Streptomyces species. Int. J. Syst. Bacteriol. 16: 313-340, 1966
19. SCHAAL, K. P.: In Chemical Methods in Bacterial Systematics. Eds., GOOGFELLOW and MINNIKIN, pp. 359-381, Academic Press, 1985
20. LECHEVALIER, M. P. & H. A. LECHEVALIER: In Actinomycete Taxonomy. Eds., A. DIETA and D. W. THAYER, pp. 227-291, Society for Industrial Microbiology, 1980
21. HUBERT, J. J.: Bioassay, p. 73, Kendall/Hunt Publishing Co., Dubuque, Iowa 1992
22. UEDA, Y., et al.: Personal communication
23. MOCEK, U.; A. R. KNAGGS, R. TSUCHIYA, T. NGUYEN, J. M. BEALE & H. G. FLOSS: Biosynthesis of the modified peptide antibiotic nosiheptide in Streptomyces actuosis. J. Am. Chem. Soc. 115: 7557-7568, 1993